According to a recent LinkedIn post from Healthera, the company is emphasizing what it describes as a revenue gap for community pharmacies that sell over-the-counter products only in-store rather than online. The post cites U.K. online shopping adoption above 80% and suggests that pharmacies relying solely on walk-ins and local footfall may be missing incremental digital revenue.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post outlines a simple revenue model, using an example of a £15 average basket value multiplied by 300 monthly online orders to illustrate potential additional monthly revenue of £4,500. It positions Healthera’s platform as enabling pharmacies to sell OTC products through their own online stores, in-app ordering, and integrations with delivery platforms such as Uber Eats.
From an investor perspective, the content suggests Healthera is targeting the digitization of OTC retail in community pharmacy, a segment that may be underpenetrated in e-commerce. If the company can drive adoption of its digital storefront and ordering solutions, it could benefit from recurring platform fees or transaction-based revenue while strengthening its position in the broader digital health and retail health ecosystem.
The emphasis on convenience and competition beyond local pharmacies indicates a strategic focus on helping independent and small-chain pharmacies compete with larger, more digitally enabled players. For investors, this may point to a scalable business model tied to structural shifts in consumer buying behavior, though the post does not provide quantitative metrics on Healthera’s current traction, client base, or revenue contribution from OTC-focused services.